Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.

Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, Pasquier RD, Schluep M, Desmeules J, Lang AB, Perron H, Faucard R, Porchet H, Hartung HP, Kappos L, Lalive PH.

Mult Scler. 2014 Nov 12. pii: 1352458514554052. [Epub ahead of print]

PMID:
25392325
[PubMed - as supplied by publisher]
2.

Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis.

Meira M, Sievers C, Hoffmann F, Rasenack M, Kuhle J, Derfuss T, Kappos L, Lindberg RL.

J Immunol Res. 2014;2014:897249. doi: 10.1155/2014/897249. Epub 2014 May 12.

PMID:
24901013
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

MiR-126: a novel route for natalizumab action?

Meira M, Sievers C, Hoffmann F, Derfuss T, Kuhle J, Kappos L, Lindberg RL.

Mult Scler. 2014 Sep;20(10):1363-70. doi: 10.1177/1352458514524998. Epub 2014 Mar 5.

PMID:
24598267
[PubMed - in process]
4.

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.

Weier K, Penner IK, Magon S, Amann M, Naegelin Y, Andelova M, Derfuss T, Stippich C, Radue EW, Kappos L, Sprenger T.

PLoS One. 2014 Jan 22;9(1):e86916. doi: 10.1371/journal.pone.0086916. eCollection 2014.

PMID:
24466290
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.

Kuhle J, Malmeström C, Axelsson M, Plattner K, Yaldizli O, Derfuss T, Giovannoni G, Kappos L, Lycke J.

Acta Neurol Scand. 2013 Dec;128(6):e33-6. doi: 10.1111/ane.12151. Epub 2013 Jun 13.

PMID:
23763388
[PubMed - indexed for MEDLINE]
6.

Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity.

Waschbisch A, Atiya M, Schaub C, Derfuss T, Schwab S, Lee DH, Müller M, Linker RA.

J Neurol Sci. 2013 Aug 15;331(1-2):72-5. doi: 10.1016/j.jns.2013.05.012. Epub 2013 Jun 2.

PMID:
23735776
[PubMed - indexed for MEDLINE]
7.

Natalizumab therapy for multiple sclerosis.

Derfuss T, Kuhle J, Lindberg R, Kappos L.

Semin Neurol. 2013 Feb;33(1):26-36. doi: 10.1055/s-0033-1343793. Epub 2013 May 25. Review.

PMID:
23709210
[PubMed - indexed for MEDLINE]
8.

T-cell response against varicella-zoster virus in fingolimod-treated MS patients.

Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T.

Neurology. 2013 Jul 9;81(2):174-81. doi: 10.1212/WNL.0b013e31829a3311. Epub 2013 May 22.

PMID:
23700335
[PubMed - indexed for MEDLINE]
9.

Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).

Preiningerova JL, Baumhackl U, Csepany T, Czaplinski A, Deisenhammer F, Derfuss T, Fabjan TH, Fazekas F, Fuchs S, Havrdova E, Ledinek AH, Illes Z, Jazbec SS, Klimova E, Komoly S, Kurca E, Linnebank M, Lisy L, Mares J, Prochazkova L, Csilla R, Szilasiova J, Stourac P, Talab R, Turcani P, Vachova M, Vecsei L, Vodusek D, Zapletalova O, Berger T.

CNS Neurosci Ther. 2013 May;19(5):302-6. doi: 10.1111/cns.12101.

PMID:
23607697
[PubMed - indexed for MEDLINE]
10.

Predicting PML in natalizumab-treated patients: can we do better?

Derfuss T, Kappos L.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1182-3. doi: 10.1136/jnnp-2012-304777. Epub 2013 Apr 20. No abstract available.

PMID:
23606737
[PubMed - indexed for MEDLINE]
11.

[What's new in multiple sclerosis therapy?].

Vaney C, Derfuss T.

Rev Med Suisse. 2013 Jan 30;9(371):285-7. German. No abstract available.

PMID:
23451607
[PubMed - indexed for MEDLINE]
12.

Neurofascin as a target for autoantibodies in peripheral neuropathies.

Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Prüss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E.

Neurology. 2012 Dec 4;79(23):2241-8. doi: 10.1212/WNL.0b013e31827689ad. Epub 2012 Oct 24.

PMID:
23100406
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Krumbholz M, Derfuss T, Hohlfeld R, Meinl E.

Nat Rev Neurol. 2012 Nov 5;8(11):613-23. doi: 10.1038/nrneurol.2012.203. Epub 2012 Oct 9. Review.

PMID:
23045237
[PubMed - indexed for MEDLINE]
14.

Personalized medicine in multiple sclerosis: hope or reality?

Derfuss T.

BMC Med. 2012 Oct 4;10:116. doi: 10.1186/1741-7015-10-116. Review.

PMID:
23035757
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Evaluating the potential benefit of interferon treatment in multiple sclerosis.

Derfuss T, Kappos L.

JAMA. 2012 Jul 18;308(3):290-1. doi: 10.1001/jama.2012.8327. No abstract available.

PMID:
22797647
[PubMed - indexed for MEDLINE]
16.

Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.

Weier K, Beck A, Magon S, Amann M, Naegelin Y, Penner IK, Thürling M, Aurich V, Derfuss T, Radue EW, Stippich C, Kappos L, Timmann D, Sprenger T.

J Neurol. 2012 Dec;259(12):2673-80. doi: 10.1007/s00415-012-6569-4. Epub 2012 Jun 19.

PMID:
22711160
[PubMed - indexed for MEDLINE]
17.

Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?

Derfuss T, Meinl E.

Curr Opin Neurol. 2012 Jun;25(3):231-8. doi: 10.1097/WCO.0b013e3283533a64. Review.

PMID:
22487571
[PubMed - indexed for MEDLINE]
18.

Continuous regional myocardial blood flow measurement: validation of a near-infrared laser Doppler device in a porcine model.

Bierbach B, Scheewe J, Derfuss T, Krug A, Schramm R, Dahm M, Kuroczynski W, Kempski O, Horstick G.

Microcirculation. 2012 Aug;19(6):485-93. doi: 10.1111/j.1549-8719.2012.00173.x.

PMID:
22372528
[PubMed - indexed for MEDLINE]
19.

Clonal expansions of CD8⁺ T cells in latently HSV-1-infected human trigeminal ganglia.

Held K, Eiglmeier I, Himmelein S, Sinicina I, Brandt T, Theil D, Dornmair K, Derfuss T.

J Neurovirol. 2012 Feb;18(1):62-8. doi: 10.1007/s13365-011-0067-9. Epub 2011 Dec 14.

PMID:
22167486
[PubMed - indexed for MEDLINE]
20.

Control of HSV-1 latency in human trigeminal ganglia--current overview.

Held K, Derfuss T.

J Neurovirol. 2011 Dec;17(6):518-27. doi: 10.1007/s13365-011-0063-0. Epub 2011 Dec 3. Review.

PMID:
22139603
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk